首页 > 最新文献

中华实用儿科临床杂志最新文献

英文 中文
Twenty key issues on severe acute respiratory syndrome coronavirus-2 vaccination in children 儿童严重急性呼吸综合征冠状病毒2型疫苗接种的20个关键问题
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.3760/cma.j.cn101070-20210913-01109
Bao-Ping Xu, Z. Wei, G. Lu, Yuejie Zheng, Xuefeng Wang, L. Feng, Zhengde Xie, Gang Liu, Yi Jiang, Xing-wang Li, R. Jiang, Jikui Deng, Miao Liu, Xia-min Lu, R. Jin, Z. Liu, Yunxia Shang, S. Shu, Y. Bai, Min Lu, Wanjun Luo, Yuxia Cui, Leping Ye, Likai Lin, Dongchi Zhao, A. Shen, J. Shao, Lijuan Xiong, Li-Wei Gao, Tianyou Wang, Z. Zhao, Yonghong Yang, K. Shen
Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is still worldwide.As a vulnerable group, severe and dead pediatric cases are also reported.Under this severe epidemic situation, children should be well protected.With the widespread vaccination of SARS-CoV-2 vaccine in adults, the infection rate have decreased.Therefore, SARS-CoV-2 vaccine inoculation for children groups step by step is of great significance to the protection of children and the prevention and control of corona virus disease 2019(COVID-19) as a whole.But the safety of children vaccinated with SARS-CoV-2 vaccine is a main concern of parents.Therefore, in order to ensure the safety of vaccination and the implementation of vaccination work, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health and the Society of Pediatrics, Chinese Medical Association organized experts to interpret the main issue of parents about SARS-CoV-2 vaccine for children, in order to answer the doubts of parents. Copyright © 2021 by the Chinese Medical Association.
严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)感染仍在世界范围内。作为弱势群体,小儿重症和死亡病例也有报道。在这种严重的疫情下,儿童应该得到很好的保护。随着成人广泛接种SARS-CoV-2疫苗,感染率有所下降。因此,对儿童群体分步接种SARS-CoV-2疫苗,对于保护儿童,从整体上防控2019冠状病毒病(COVID-19)具有重要意义。但接种了SARS-CoV-2疫苗的儿童的安全性是家长们主要关心的问题。为此,为确保疫苗接种的安全性和疫苗接种工作的实施,国家呼吸系统疾病临床研究中心、国家儿童健康中心和中华医学会儿科学学会组织专家对家长关于儿童新冠肺炎疫苗的主要问题进行了解读,为家长解答疑惑。中华医学会版权所有©2021。
{"title":"Twenty key issues on severe acute respiratory syndrome coronavirus-2 vaccination in children","authors":"Bao-Ping Xu, Z. Wei, G. Lu, Yuejie Zheng, Xuefeng Wang, L. Feng, Zhengde Xie, Gang Liu, Yi Jiang, Xing-wang Li, R. Jiang, Jikui Deng, Miao Liu, Xia-min Lu, R. Jin, Z. Liu, Yunxia Shang, S. Shu, Y. Bai, Min Lu, Wanjun Luo, Yuxia Cui, Leping Ye, Likai Lin, Dongchi Zhao, A. Shen, J. Shao, Lijuan Xiong, Li-Wei Gao, Tianyou Wang, Z. Zhao, Yonghong Yang, K. Shen","doi":"10.3760/cma.j.cn101070-20210913-01109","DOIUrl":"https://doi.org/10.3760/cma.j.cn101070-20210913-01109","url":null,"abstract":"Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is still worldwide.As a vulnerable group, severe and dead pediatric cases are also reported.Under this severe epidemic situation, children should be well protected.With the widespread vaccination of SARS-CoV-2 vaccine in adults, the infection rate have decreased.Therefore, SARS-CoV-2 vaccine inoculation for children groups step by step is of great significance to the protection of children and the prevention and control of corona virus disease 2019(COVID-19) as a whole.But the safety of children vaccinated with SARS-CoV-2 vaccine is a main concern of parents.Therefore, in order to ensure the safety of vaccination and the implementation of vaccination work, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health and the Society of Pediatrics, Chinese Medical Association organized experts to interpret the main issue of parents about SARS-CoV-2 vaccine for children, in order to answer the doubts of parents. Copyright © 2021 by the Chinese Medical Association.","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"36 1","pages":"1368-1372"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70011076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experts' consensus on severe acute respiratory syndrome coronavirus-2 vaccination of children 专家对儿童接种冠状病毒2型疫苗的共识
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.3760/cma.j.cn101070-20210902-01057
Yuejie Zheng, Xuefeng Wang, L. Feng, Zhengde Xie, Yi Jiang, G. Lu, Xing-wang Li, R. Jiang, Jikui Deng, Miao Liu, Bao-Ping Xu, Z. Wei, Gang Liu, Xia-min Lu, R. Jin, Z. Liu, Yunxia Shang, S. Shu, Y. Bai, Min Lu, Wanjun Luo, Yuxia Cui, Leping Ye, Likai Lin, Dongchi Zhao, A. Shen, J. Shao, Lijuan Xiong, Li-Wei Gao, Tianyou Wang, Z. Zhao, Yonghong Yang, K. Shen
At present, severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is still rampant worldwide.As of September 10, 2021, there were about 222 million confirmed cases of corona virus disease 2019(COVID-19)and more than 4.6 million deaths worldwide.With the development of COVID-19 vaccines and the gradual vaccination worldwide, the increasing number of cases in children and unvaccinated young people has drawn attention.According to World Health Organization surveillance data, the proportion of COVID-19 infection cases in children gradually increased, and the proportion of cases in the age groups of under 5 years and 5-14 years increased from 1.0% and 2.5% in January 2020 to 2.0% and 8.7% in July 2021, respectively.At present, billions of adults have been vaccinated with various COVID-19 vaccines worldwide, and their protective effects including reducing infection and transmission, reducing severe disease and hospitalization, and reducing death, as well as high safety have been confirmed.Canada, the United States, Europe and other countries have approved the emergency COVID-19 vaccination in children and adolescents aged 12 to 17 years, and China has also approved the phased vaccination of COVID-19 vaccination in children and adolescents aged 3 to 17 years. For smooth advancement and implementation of COVID-19 vaccination in children, academic institutions, including National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, and The Society of Pediatrics, Chinese Medical Association organized relevant experts to reach this consensus on COVID-19 vaccination in children. Copyright © 2021 by the Chinese Medical Association.
目前,严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)感染在全球范围内仍很猖獗。截至2021年9月10日,全球约有2.22亿冠状病毒病(COVID-19)确诊病例,460多万人死亡。随着COVID-19疫苗的开发和全球疫苗接种的逐步开展,儿童和未接种疫苗的年轻人中病例的增加引起了人们的关注。世界卫生组织监测数据显示,新冠肺炎儿童感染病例占比逐步上升,5岁以下和5-14岁年龄组病例占比分别从2020年1月的1.0%和2.5%上升至2021年7月的2.0%和8.7%。目前,全球已有数十亿成年人接种了各种COVID-19疫苗,其保护作用已得到证实,包括减少感染和传播,减少重症和住院,减少死亡,以及高度安全性。加拿大、美国、欧洲等国已批准12至17岁儿童和青少年紧急接种新冠肺炎疫苗,中国也已批准3至17岁儿童和青少年分阶段接种新冠肺炎疫苗。为顺利推进和实施儿童新冠肺炎疫苗接种工作,国家呼吸疾病临床研究中心、国家儿童卫生中心、中华医学会儿科学学会等学术机构组织相关专家就儿童新冠肺炎疫苗接种达成共识。中华医学会版权所有©2021。
{"title":"Experts' consensus on severe acute respiratory syndrome coronavirus-2 vaccination of children","authors":"Yuejie Zheng, Xuefeng Wang, L. Feng, Zhengde Xie, Yi Jiang, G. Lu, Xing-wang Li, R. Jiang, Jikui Deng, Miao Liu, Bao-Ping Xu, Z. Wei, Gang Liu, Xia-min Lu, R. Jin, Z. Liu, Yunxia Shang, S. Shu, Y. Bai, Min Lu, Wanjun Luo, Yuxia Cui, Leping Ye, Likai Lin, Dongchi Zhao, A. Shen, J. Shao, Lijuan Xiong, Li-Wei Gao, Tianyou Wang, Z. Zhao, Yonghong Yang, K. Shen","doi":"10.3760/cma.j.cn101070-20210902-01057","DOIUrl":"https://doi.org/10.3760/cma.j.cn101070-20210902-01057","url":null,"abstract":"At present, severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is still rampant worldwide.As of September 10, 2021, there were about 222 million confirmed cases of corona virus disease 2019(COVID-19)and more than 4.6 million deaths worldwide.With the development of COVID-19 vaccines and the gradual vaccination worldwide, the increasing number of cases in children and unvaccinated young people has drawn attention.According to World Health Organization surveillance data, the proportion of COVID-19 infection cases in children gradually increased, and the proportion of cases in the age groups of under 5 years and 5-14 years increased from 1.0% and 2.5% in January 2020 to 2.0% and 8.7% in July 2021, respectively.At present, billions of adults have been vaccinated with various COVID-19 vaccines worldwide, and their protective effects including reducing infection and transmission, reducing severe disease and hospitalization, and reducing death, as well as high safety have been confirmed.Canada, the United States, Europe and other countries have approved the emergency COVID-19 vaccination in children and adolescents aged 12 to 17 years, and China has also approved the phased vaccination of COVID-19 vaccination in children and adolescents aged 3 to 17 years. For smooth advancement and implementation of COVID-19 vaccination in children, academic institutions, including National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, and The Society of Pediatrics, Chinese Medical Association organized relevant experts to reach this consensus on COVID-19 vaccination in children. Copyright © 2021 by the Chinese Medical Association.","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"36 1","pages":"1361-1367"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70011064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Multisystem inflammatory syndrome in children related with 2019 Novel Coronavirus infection 2019年新型冠状病毒感染相关儿童多系统炎症综合征
Q4 Medicine Pub Date : 2020-08-05 DOI: 10.3760/CMA.J.CN101070-20200710-01156
Zhiguan Feng, Y. Bao, Yonghong Yang, Yuejie Zheng, K. Shen
Multisystem inflammatory syndrome in children (MIS-C) reported in the United States and European countries is a disease with multi-organ involved symptoms related with 2019 Novel Coronavirus infection, which has never been reported in China Although its symptoms are similar to Kawasaki disease, MIS-C has characteristics of higher frequency in older children and adolescents, gastrointestinal symptoms, haemodynamic instability, myocarditis and elevated inflammatory markers Most of the children need intensive care The pathogenesis and long-term prognosis of the disease need further study Copyright © 2020 by the Chinese Medical Association
美国和欧洲国家报道的儿童多系统炎症综合征(MIS-C)是一种与2019年新型冠状病毒感染相关的多器官受累症状的疾病,在中国从未报道过。尽管其症状与川崎病相似,但MIS-C在年龄较大的儿童和青少年中具有更高频率的特征,胃肠道症状、血液动力学不稳定、心肌炎和炎症标志物升高大多数儿童需要重症监护该疾病的发病机制和长期预后需要进一步研究版权所有©2020中华医学会
{"title":"Multisystem inflammatory syndrome in children related with 2019 Novel Coronavirus infection","authors":"Zhiguan Feng, Y. Bao, Yonghong Yang, Yuejie Zheng, K. Shen","doi":"10.3760/CMA.J.CN101070-20200710-01156","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20200710-01156","url":null,"abstract":"Multisystem inflammatory syndrome in children (MIS-C) reported in the United States and European countries is a disease with multi-organ involved symptoms related with 2019 Novel Coronavirus infection, which has never been reported in China Although its symptoms are similar to Kawasaki disease, MIS-C has characteristics of higher frequency in older children and adolescents, gastrointestinal symptoms, haemodynamic instability, myocarditis and elevated inflammatory markers Most of the children need intensive care The pathogenesis and long-term prognosis of the disease need further study Copyright © 2020 by the Chinese Medical Association","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"35 1","pages":"1121-1124"},"PeriodicalIF":0.0,"publicationDate":"2020-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42119195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Special issues in diagnosis of Kawasaki disease 川崎病诊断中的特殊问题
Q4 Medicine Pub Date : 2020-07-08 DOI: 10.3760/CMA.J.CN101070-20200706-01134
Qing-you Zhang, Junbao Du
Kawasaki disease (KD) is an acute, self-limiting, and medium-sized vasculitis, which has been the commonest cause of acquired heart disease in children in developed countries Without timely diagnosis and treatment, up-to 25% of the affected children may develop coronary artery abnormalities (CAA) Due to the lack of the specific diagnostic method, KD is mainly diagnosed according to the clinical criteria As a result, typical KD is recognized easily, but it is a big challenge to diagnose KD patients with incomplete or atypical symptoms The pandemic of novel coronavirus disease 2019 (COVID-19) around the world makes the diagnosis of KD even more complex In this review, hot issues in diagnosing KD were discussed according to the 2017 guidelines for diagnosis and treatment of KD recently published by the American Heart Association (AHA), expecting to provide help for diagnosis of KD children Copyright © 2020 by the Chinese Medical Association
川崎病(Kawasaki disease, KD)是一种急性、自限性、中型血管炎,是发达国家儿童获得性心脏病最常见的病因,若不及时诊断和治疗,高达25%的患儿可发生冠状动脉异常(coronary artery异常,CAA)。由于缺乏具体的诊断方法,主要根据临床标准进行诊断,因此很容易识别出典型的KD。新型冠状病毒病2019 (COVID-19)在全球范围内的大流行使得KD的诊断更加复杂,本文根据美国心脏协会(AHA)最近发布的2017年KD诊疗指南,对KD诊断中的热点问题进行了讨论,希望能为KD患儿的诊断提供帮助版权所有©2020中华医学会
{"title":"Special issues in diagnosis of Kawasaki disease","authors":"Qing-you Zhang, Junbao Du","doi":"10.3760/CMA.J.CN101070-20200706-01134","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20200706-01134","url":null,"abstract":"Kawasaki disease (KD) is an acute, self-limiting, and medium-sized vasculitis, which has been the commonest cause of acquired heart disease in children in developed countries Without timely diagnosis and treatment, up-to 25% of the affected children may develop coronary artery abnormalities (CAA) Due to the lack of the specific diagnostic method, KD is mainly diagnosed according to the clinical criteria As a result, typical KD is recognized easily, but it is a big challenge to diagnose KD patients with incomplete or atypical symptoms The pandemic of novel coronavirus disease 2019 (COVID-19) around the world makes the diagnosis of KD even more complex In this review, hot issues in diagnosing KD were discussed according to the 2017 guidelines for diagnosis and treatment of KD recently published by the American Heart Association (AHA), expecting to provide help for diagnosis of KD children Copyright © 2020 by the Chinese Medical Association","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"35 1","pages":"961-964"},"PeriodicalIF":0.0,"publicationDate":"2020-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43956057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prognosis and rehabilitation of sepsis-associated encephalopathy 败血症相关性脑病的预后和康复
Q4 Medicine Pub Date : 2020-04-08 DOI: 10.3760/CMA.J.CN101070-20200308-00347
Xu-Hua Ge, H. Miao
Sepsis-associated encephalopathy (SAE) is a serious complication of sepsis, which can greatly increase the mortality of patients with sepsis, and may result in prolonged cognitive dysfunction in SAE survivors.Therefore SAE has received more and more attention in the field of critical illness.However, there are few studies on the mechanism of poor prognosis and possible predictors of SAE, and no specific rehabilitation methods have been reported.In this article, progress in the research on the prognosis and rehabilitation of SAE is summarized, in order to provide a reference for the long-term prognosis and rehabilitation treatment of severe sepsis in children. Key words: Sepsis-associated encephalopathy; Prognosis; Rehabilitation
脓毒症相关性脑病(SAE)是脓毒症的一种严重并发症,它会大大增加脓毒症患者的死亡率,并可能导致SAE幸存者的长期认知功能障碍。因此,SAE在危重症领域受到越来越多的关注。然而,关于不良预后的机制和SAE的可能预测因素的研究很少,也没有具体的康复方法的报道。本文综述了SAE的预后和康复研究进展,以期为儿童重症脓毒症的长期预后和康复治疗提供参考。关键词:脓毒症相关性脑病;预后;康复
{"title":"Prognosis and rehabilitation of sepsis-associated encephalopathy","authors":"Xu-Hua Ge, H. Miao","doi":"10.3760/CMA.J.CN101070-20200308-00347","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20200308-00347","url":null,"abstract":"Sepsis-associated encephalopathy (SAE) is a serious complication of sepsis, which can greatly increase the mortality of patients with sepsis, and may result in prolonged cognitive dysfunction in SAE survivors.Therefore SAE has received more and more attention in the field of critical illness.However, there are few studies on the mechanism of poor prognosis and possible predictors of SAE, and no specific rehabilitation methods have been reported.In this article, progress in the research on the prognosis and rehabilitation of SAE is summarized, in order to provide a reference for the long-term prognosis and rehabilitation treatment of severe sepsis in children. \u0000 \u0000Key words: \u0000Sepsis-associated encephalopathy; Prognosis; Rehabilitation","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"35 1","pages":"419-421"},"PeriodicalIF":0.0,"publicationDate":"2020-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48221016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A single-center study of serum sickness caused by rabbit antithymosinglobulin therapy in children with acquired aplastic anemia 兔抗胸腺单球蛋白治疗儿童获得性再生障碍性贫血血清病的单中心研究
Q4 Medicine Pub Date : 2020-04-08 DOI: 10.3760/CMA.J.CN101070-20190322-00230
Bixian Yang, Rui Zhang, Liqiang Zhang, Jie Ma, J. Yao, Ying Wu, R. Wu
Objective To investigate the related factors of the serum sickness morbidity in the treatment of children with acquired aplastic anemia (AA) by rabbit antithymosinglobulin (ATG), summarize the clinical characte-ristics of serum sickness and evaluate the influence of serum sickness on the prognosis of AA. Methods The data of patients diagnosed as AA after treated with immunosuppressive therapy (IST) in Beijing Children′s Hospital, Capital Medical University, from March 2016 to December 2018 were collected, and the onset time, clinical manifestations, treatment, and prognosis of serum sickness were analyzed. Results A total of 48 cases were enrolled, with the median age of 5 years and 5 months (ranging from 2 years and 1 month to 15 years and 6 months), and the proportion of male to female was 1.4∶1.0, 75.0% of the patients(36/48 cases) developed serum sickness.The median onset time was the 11th day and 72.2% of the patients (26/48 cases) occurred from the 7th to the 14th day during IST.The 3 main clinical manifestations included arthralgia (63.9%, 23 cases), fever (52.7%, 19 cases) and rash (52.7%, 19 cases). There was no significant difference in peripheral blood leukocytes, neutrophils and lymphocytes between the patients with serum sickness and patients without serum sickness before IST and during serum sickness (all P>0.05). The incidence of serum sickness in children who received continuous glucocorticoid prophylaxis after IST (2/12 cases, 16.6%) was lower than that of those who did not (34/36 cases, 94.4%), and the difference was significant (χ2=29.037, P 0.05). Conclusion Children with AA are prone to develop serum sickness after IST treatment.The peak period of incidence of serum sickness is the second week during IST, and the main clinical manifestations of serum sickness include arthralgia, fever, and rash.There is no correlation between the incidence of serum sickness and the blood routine test before IST and during serum sickness.The incidence of serum sickness can be reduced by giving glucocorticoid prophylaxis, and glucocorticoid is still effective after the onset of the serum sickness.There is no correlation between the morbidity of serum sickness and the prognosis of AA treated with IST. Key words: Child; Aplastic anemia; Immunosuppressive therapy; Serum sickness
目的探讨兔抗胸腺单球蛋白(ATG)治疗儿童获得性再生障碍性贫血(AA)血清病发病的相关因素,总结血清病的临床特点,评价血清病对AA预后的影响。方法收集2016年3月至2018年12月首都医科大学附属北京儿童医院经免疫抑制治疗(IST)诊断为AA的患者资料,分析血清病发病时间、临床表现、治疗及预后。结果共纳入48例,中位年龄为5岁5个月(2岁1个月~ 15岁6个月),男女比例为1.4∶1.0,出现血清病的占75.0%(36/48)。中位发病时间为第11天,72.2%(26/48)的患者发病时间为第7 ~ 14天。主要临床表现为关节痛(63.9%,23例)、发热(52.7%,19例)和皮疹(52.7%,19例)。血清病患者与非血清病患者外周血白细胞、中性粒细胞和淋巴细胞在IST前和血清病期间差异无统计学意义(P < 0.05)。IST术后持续接受糖皮质激素预防治疗的患儿血清疾病发生率(2/12例,16.6%)低于未接受糖皮质激素预防治疗的患儿(34/36例,94.4%),差异有统计学意义(χ2=29.037, p0.05)。结论AA患儿经IST治疗后易发生血清病。血清病的发病高峰期为IST的第2周,血清病的主要临床表现为关节痛、发热、皮疹。血清病的发生率与筛查前和血清病期间的血常规检查无相关性。血清病的发病率可通过给予糖皮质激素预防来降低,并且在血清病发病后糖皮质激素仍然有效。血清疾病的发病率与应用IST治疗AA的预后无相关性。关键词:儿童;再生障碍性贫血;免疫抑制治疗;血清病
{"title":"A single-center study of serum sickness caused by rabbit antithymosinglobulin therapy in children with acquired aplastic anemia","authors":"Bixian Yang, Rui Zhang, Liqiang Zhang, Jie Ma, J. Yao, Ying Wu, R. Wu","doi":"10.3760/CMA.J.CN101070-20190322-00230","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20190322-00230","url":null,"abstract":"Objective \u0000To investigate the related factors of the serum sickness morbidity in the treatment of children with acquired aplastic anemia (AA) by rabbit antithymosinglobulin (ATG), summarize the clinical characte-ristics of serum sickness and evaluate the influence of serum sickness on the prognosis of AA. \u0000 \u0000 \u0000Methods \u0000The data of patients diagnosed as AA after treated with immunosuppressive therapy (IST) in Beijing Children′s Hospital, Capital Medical University, from March 2016 to December 2018 were collected, and the onset time, clinical manifestations, treatment, and prognosis of serum sickness were analyzed. \u0000 \u0000 \u0000Results \u0000A total of 48 cases were enrolled, with the median age of 5 years and 5 months (ranging from 2 years and 1 month to 15 years and 6 months), and the proportion of male to female was 1.4∶1.0, 75.0% of the patients(36/48 cases) developed serum sickness.The median onset time was the 11th day and 72.2% of the patients (26/48 cases) occurred from the 7th to the 14th day during IST.The 3 main clinical manifestations included arthralgia (63.9%, 23 cases), fever (52.7%, 19 cases) and rash (52.7%, 19 cases). There was no significant difference in peripheral blood leukocytes, neutrophils and lymphocytes between the patients with serum sickness and patients without serum sickness before IST and during serum sickness (all P>0.05). The incidence of serum sickness in children who received continuous glucocorticoid prophylaxis after IST (2/12 cases, 16.6%) was lower than that of those who did not (34/36 cases, 94.4%), and the difference was significant (χ2=29.037, P 0.05). \u0000 \u0000 \u0000Conclusion \u0000Children with AA are prone to develop serum sickness after IST treatment.The peak period of incidence of serum sickness is the second week during IST, and the main clinical manifestations of serum sickness include arthralgia, fever, and rash.There is no correlation between the incidence of serum sickness and the blood routine test before IST and during serum sickness.The incidence of serum sickness can be reduced by giving glucocorticoid prophylaxis, and glucocorticoid is still effective after the onset of the serum sickness.There is no correlation between the morbidity of serum sickness and the prognosis of AA treated with IST. \u0000 \u0000 \u0000Key words: \u0000Child; Aplastic anemia; Immunosuppressive therapy; Serum sickness","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"35 1","pages":"436-439"},"PeriodicalIF":0.0,"publicationDate":"2020-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42841471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chromosome karyotype of bone marrow and its clinical significance in the first diagnosis of neuroblastoma with bone marrow metastasis 骨髓染色体核型及其在神经母细胞瘤骨髓转移早期诊断中的临床意义
Q4 Medicine Pub Date : 2020-04-08 DOI: 10.3760/CMA.J.CN101070-20190130-00072
Xiao Xu, Zhixia Yue, Yan Su, Bin Li, Bei Li, Wen Zhao, Qian Zhao, M. Jin, Da-wei Zhang, Yi Liu, W. Guo, Xiao-li Ma
Objective To summarize and analyze the results of chromosome karyotype in children with neuroblastoma (NB) with bone marrow metastasis at first diagnosis, and to discuss the clinical significance. Methods G-banding was applied to the analysis of chromosome karyotype of patients who were regularly treated in the Hematological and Oncology Center in Beijing Children′s Hospital from January 2015 to December 2017, and all the patients were followed up until December 31, 2018.Their clinical features and prognosis were analyzed. Results (1) There were 120 cases with bone marrow metastasis, including 74 boys and 46 girls, and 98 cases (81.7%) were ≥ 18 months.Among 60 cases with normal chromosome, 56 cases (93.3%) were in International Neuroblastoma Staging System(INSS)-Ⅳ phase, and 4 cases in INSS-Ⅳs phase; there were 2 low-risk (LR) cases, 9 intermediate-risk (MR) cases, and 49 high-risk (HR) cases (81.7%); 7 cases had MYCN gene amplifications.All 60 patients with chromosome abnormalities were in INSS-Ⅳ phase; there was 1 case in MR and 59 cases (98.3%) in HR; 14 cases had MYCN gene amplifications.(2) Among 60 children (50%) with chromosome abnormalities, 4 children had number abnormalities, 14 children had structural abnormalities, and 42 children had both number and structural chromosome abnormalities.Chromosome 21, 10, 11 deletions were the most common in number abnormalities; structural abnormalities involving 11q, 1p, 3p segments had a high incidence.(3) Seventeen cases of children with normal chromosome had tumor progression or recurrence during the 4 to 44-month follow-up period, and 31 cases of children with chromosome abnormalities had tumor progression or recurrence during the 2 to 42-month follow-up period.The 3-year overall survival rate and event-free survival rate of all children were 60.0% and 48.4%, respectively; children in the normal chromosome group had a 3-year overall survival rate of 74.2% and an event-free survival rate of 65.7%; the 3-year overall survival rate and event-free survival rate of children with chromosome abnormalities were 47.5% and 24.9%, respectively.Most children suffering from tumor progression or recurrence had chromosome 10 deletion, and abnormal structure of 11q, 1p, 2p segments. Conclusion The chromosomal abnormality rate of Nb children's tumor cells is high, but the repetition rate is low, and the individual difference is obvious.The deletion of chromosome 10, abnormal regional structure of 11q, 1p and 2p segments may be poor prognostic factors for NB.Chromosome karyotype analysis of bone marrow samples is feasible, which can provide a basis for more accurate risk stratification and treatment. Key words: Neuroblastoma; Bone marrow metastasis; Chromosome karyotype
目的总结分析儿童神经母细胞瘤(NB)骨髓转移初诊时染色体核型结果,探讨其临床意义。方法应用G显带技术对2015年1月至2017年12月在北京儿童医院血液肿瘤中心定期就诊的患者进行染色体核型分析,随访至2018年12月31日,分析其临床特点和预后。结果(1)骨髓转移患者120例,其中男孩74例,女孩46例,≥18个月者98例(81.7%)。60例染色体正常者中,国际神经母细胞瘤分期系统(INSS)-Ⅳ期56例(93.3%),INSS-Ⅳs期4例;低危(LR)2例,中危(MR)9例,高危(HR)49例(81.7%);MYCN基因扩增7例。60例染色体异常患者均为INSS-Ⅳ期;MR 1例,HR 59例(98.3%);MYCN基因扩增14例。(2) 在60名(50%)染色体异常的儿童中,4名儿童出现数量异常,14名儿童出现结构异常,42名儿童同时出现数量和结构染色体异常。染色体21、10、11缺失是数量异常中最常见的;11q、1p、3p节段的结构异常发生率较高。(3) 17例染色体正常的儿童在4至44个月的随访期间出现肿瘤进展或复发,31例染色体异常的儿童在2至42个月的跟踪期间出现肿瘤发展或复发。所有儿童的3年总生存率和无事件生存率分别为60.0%和48.4%;正常染色体组儿童的3年总生存率为74.2%,无事件生存率为65.7%;染色体异常儿童的3年总生存率和无事件生存率分别为47.5%和24.9%。大多数肿瘤进展或复发的儿童都有10号染色体缺失,11q、1p、2p节段结构异常。结论Nb儿童肿瘤细胞染色体异常率高,但重复率低,个体差异明显。10号染色体的缺失、11q、1p和2p区段的异常区域结构可能是NB的不良预后因素。骨髓样本的染色体核型分析是可行的,可以为更准确的风险分层和治疗提供依据。关键词:神经母细胞瘤;骨髓转移;染色体核型
{"title":"Chromosome karyotype of bone marrow and its clinical significance in the first diagnosis of neuroblastoma with bone marrow metastasis","authors":"Xiao Xu, Zhixia Yue, Yan Su, Bin Li, Bei Li, Wen Zhao, Qian Zhao, M. Jin, Da-wei Zhang, Yi Liu, W. Guo, Xiao-li Ma","doi":"10.3760/CMA.J.CN101070-20190130-00072","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20190130-00072","url":null,"abstract":"Objective \u0000To summarize and analyze the results of chromosome karyotype in children with neuroblastoma (NB) with bone marrow metastasis at first diagnosis, and to discuss the clinical significance. \u0000 \u0000 \u0000Methods \u0000G-banding was applied to the analysis of chromosome karyotype of patients who were regularly treated in the Hematological and Oncology Center in Beijing Children′s Hospital from January 2015 to December 2017, and all the patients were followed up until December 31, 2018.Their clinical features and prognosis were analyzed. \u0000 \u0000 \u0000Results \u0000(1) There were 120 cases with bone marrow metastasis, including 74 boys and 46 girls, and 98 cases (81.7%) were ≥ 18 months.Among 60 cases with normal chromosome, 56 cases (93.3%) were in International Neuroblastoma Staging System(INSS)-Ⅳ phase, and 4 cases in INSS-Ⅳs phase; there were 2 low-risk (LR) cases, 9 intermediate-risk (MR) cases, and 49 high-risk (HR) cases (81.7%); 7 cases had MYCN gene amplifications.All 60 patients with chromosome abnormalities were in INSS-Ⅳ phase; there was 1 case in MR and 59 cases (98.3%) in HR; 14 cases had MYCN gene amplifications.(2) Among 60 children (50%) with chromosome abnormalities, 4 children had number abnormalities, 14 children had structural abnormalities, and 42 children had both number and structural chromosome abnormalities.Chromosome 21, 10, 11 deletions were the most common in number abnormalities; structural abnormalities involving 11q, 1p, 3p segments had a high incidence.(3) Seventeen cases of children with normal chromosome had tumor progression or recurrence during the 4 to 44-month follow-up period, and 31 cases of children with chromosome abnormalities had tumor progression or recurrence during the 2 to 42-month follow-up period.The 3-year overall survival rate and event-free survival rate of all children were 60.0% and 48.4%, respectively; children in the normal chromosome group had a 3-year overall survival rate of 74.2% and an event-free survival rate of 65.7%; the 3-year overall survival rate and event-free survival rate of children with chromosome abnormalities were 47.5% and 24.9%, respectively.Most children suffering from tumor progression or recurrence had chromosome 10 deletion, and abnormal structure of 11q, 1p, 2p segments. \u0000 \u0000 \u0000Conclusion \u0000The chromosomal abnormality rate of Nb children's tumor cells is high, but the repetition rate is low, and the individual difference is obvious.The deletion of chromosome 10, abnormal regional structure of 11q, 1p and 2p segments may be poor prognostic factors for NB.Chromosome karyotype analysis of bone marrow samples is feasible, which can provide a basis for more accurate risk stratification and treatment. \u0000 \u0000 \u0000Key words: \u0000Neuroblastoma; Bone marrow metastasis; Chromosome karyotype","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"35 1","pages":"430-435"},"PeriodicalIF":0.0,"publicationDate":"2020-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41358237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive value of platelet distribution width on prognosis of neuroblastoma 血小板分布宽度对神经母细胞瘤预后的预测价值
Q4 Medicine Pub Date : 2020-04-08 DOI: 10.3760/CMA.J.CN101070-20191110-01116
Linnan Zhang, Yu-feng Liu, S. Su, Linlin Wei, Bai Li, Haiyan Rao, S. Mao
Objective To discuss whether platelet distribution width (PDW) can effectively predict the prognosis of neuroblastoma (NB). Methods The clinical data of 67 NB patients in the First Affiliated Hospital of Zhengzhou University between January 2014 and January 2018 were retrospectively analyzed.They were divided into low PDW group and high PDW group according to the PDW level, and the differences in clinical indicators between the 2 groups were compared.The prognostic effects of PDW were assessed by using the Kaplan-Meier method and Cox regression model. Results Among the 67 patients, 41 cases were male, 26 cases were female, with the ratio of male to female being 1.58∶1.00, and the average age was 44 months (2-156 months). Five cases were in stage Ⅰ, 1 case in stage Ⅱ, 15 cases in stage Ⅲ and 46 cases in stage Ⅳ.At the first time of diagnosis, there were 14 cases with age ≤ 18 months, 53 cases with age > 18 months, 47 cases with neuron specific enolase (NSE) level ≥ 100 μg/L, 20 cases with NSE level 0.05). The proportion of high-risk patients, the level of NSE, bone marrow metastasis rate, MYCN gene amplification rate and the red blood cell distribution width in the high PDW group were significantly higher than those in the low PDW group, but the high PDW group had a lower level of thrombocytocrit than the low PDW group, and the differences were statistically significant(all P<0.05). Survival analysis revealed that the 2-year overall survival of the low PDW group was significantly higher than that of the high PDW group (69.8% vs.25.3%, χ2=15.761, P<0.05). Univariate analysis showed that NSE (HR=6.606, 95%CI: 2.018-21.620), MYCN gene (HR=1.977, 95%CI: 0.794-4.919), tumor risk stratification (HR=5.926, 95%CI: 1.416-24.794), PDW (HR=4.036, 95%CI: 1.957-8.322), and red blood cell distribution width (HR=1.120, 95%CI: 1.005-1.249) were the adverse factors affecting the overall survival, and thrombocytocrit was a protective factor for the prognosis of NB.Multivariate analysis indicated that PDW was an independent risk factor of NB (HR=2.524, 95%CI: 1.017-6.264, P=0.046). Conclusions There is a good consistency between the increase of PDW and the known prognostic risk factors, elevated tumor markers and bone marrow metastasis.Increased PDW is associated with poor prognosis in NB patients, and PDW is an independent risk factor for the poor prognosis of NB. Key words: Neuroblastoma; Platelet distribution width; Prognosis; Overall survival
目的探讨血小板分布宽度(PDW)是否能有效预测神经母细胞瘤(NB)的预后。方法回顾性分析郑州大学第一附属医院2014年1月至2018年1月收治的67例NB患者的临床资料。根据PDW水平将其分为低PDW组和高PDW组,并比较两组临床指标的差异。采用Kaplan-Meier方法和Cox回归模型评估PDW的预后影响。结果67例患者中,男性41例,女性26例,男女比例为1.58∶1.00,平均年龄44个月(2~156个月)。Ⅰ期5例,Ⅱ期1例,Ⅲ期15例,Ⅳ期46例。首次诊断时,年龄≤18个月的14例,年龄>18个月的53例,神经元特异性烯醇化酶(NSE)水平≥100μg/L的47例,NSE水平0.05的20例,高PDW组的MYCN基因扩增率和红细胞分布宽度显著高于低PDW组,生存分析显示,低PDW组的2年总生存率显著高于高PDW组(69.8%vs.25.3%,χ2=15.761,P<0.05),肿瘤风险分层(HR=5.926,95%CI:1.416-24.794)、PDW(HR=4.036,95%CI:1.957-8.322)和红细胞分布宽度(HR=1.120,95%CI:1.005-1.249)是影响总生存率的不利因素,多因素分析表明PDW是NB的独立危险因素(HR=2.524,95%CI:1.017-6.264,P=0.046)。PDW增加与NB患者的不良预后相关,PDW是NB预后不良的独立危险因素。关键词:神经母细胞瘤;血小板分布宽度;预后;总体生存率
{"title":"Predictive value of platelet distribution width on prognosis of neuroblastoma","authors":"Linnan Zhang, Yu-feng Liu, S. Su, Linlin Wei, Bai Li, Haiyan Rao, S. Mao","doi":"10.3760/CMA.J.CN101070-20191110-01116","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20191110-01116","url":null,"abstract":"Objective \u0000To discuss whether platelet distribution width (PDW) can effectively predict the prognosis of neuroblastoma (NB). \u0000 \u0000 \u0000Methods \u0000The clinical data of 67 NB patients in the First Affiliated Hospital of Zhengzhou University between January 2014 and January 2018 were retrospectively analyzed.They were divided into low PDW group and high PDW group according to the PDW level, and the differences in clinical indicators between the 2 groups were compared.The prognostic effects of PDW were assessed by using the Kaplan-Meier method and Cox regression model. \u0000 \u0000 \u0000Results \u0000Among the 67 patients, 41 cases were male, 26 cases were female, with the ratio of male to female being 1.58∶1.00, and the average age was 44 months (2-156 months). Five cases were in stage Ⅰ, 1 case in stage Ⅱ, 15 cases in stage Ⅲ and 46 cases in stage Ⅳ.At the first time of diagnosis, there were 14 cases with age ≤ 18 months, 53 cases with age > 18 months, 47 cases with neuron specific enolase (NSE) level ≥ 100 μg/L, 20 cases with NSE level 0.05). The proportion of high-risk patients, the level of NSE, bone marrow metastasis rate, MYCN gene amplification rate and the red blood cell distribution width in the high PDW group were significantly higher than those in the low PDW group, but the high PDW group had a lower level of thrombocytocrit than the low PDW group, and the differences were statistically significant(all P<0.05). Survival analysis revealed that the 2-year overall survival of the low PDW group was significantly higher than that of the high PDW group (69.8% vs.25.3%, χ2=15.761, P<0.05). Univariate analysis showed that NSE (HR=6.606, 95%CI: 2.018-21.620), MYCN gene (HR=1.977, 95%CI: 0.794-4.919), tumor risk stratification (HR=5.926, 95%CI: 1.416-24.794), PDW (HR=4.036, 95%CI: 1.957-8.322), and red blood cell distribution width (HR=1.120, 95%CI: 1.005-1.249) were the adverse factors affecting the overall survival, and thrombocytocrit was a protective factor for the prognosis of NB.Multivariate analysis indicated that PDW was an independent risk factor of NB (HR=2.524, 95%CI: 1.017-6.264, P=0.046). \u0000 \u0000 \u0000Conclusions \u0000There is a good consistency between the increase of PDW and the known prognostic risk factors, elevated tumor markers and bone marrow metastasis.Increased PDW is associated with poor prognosis in NB patients, and PDW is an independent risk factor for the poor prognosis of NB. \u0000 \u0000 \u0000Key words: \u0000Neuroblastoma; Platelet distribution width; Prognosis; Overall survival","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"35 1","pages":"440-444"},"PeriodicalIF":0.0,"publicationDate":"2020-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49465176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of etiology and prognosis of 120 children with pediatric acute liver failure 120例儿童急性肝功能衰竭的病因及预后分析
Q4 Medicine Pub Date : 2020-04-08 DOI: 10.3760/CMA.J.CN101070-20191108-01113
T. Jiang, Wen-xian Ou-yang, Y. Tan, Lian Tang, Hui Zhang, Z. Kang, Xi Zheng, Shuangjie Li
Objective To investigate the etiology, prognosis and prognostic factors of pediatric acute liver failure(PALF), in order to provide the basis for clinical treatment of PALF. Methods The clinical data of children with PALF hospitalized at Hunan Children′s Hospital from May 2008 to May 2018 were collected, and the causes and prognosis were analyzed.According to the prognosis, the patients were divided into the death group and the survival group, whose biochemical indexes were then compared.After that, the statistical analysis of different data were carried out by using t-test, Wilcoxon test and χ2 test separately. Results In 120 PALF cases, there were 68 males and 52 females, and there were 36 infants, 34 toddlers, 22 preschoolers and 28 school-age children.Twenty cases (16.7%) were caused by sepsis, 19 cases (15.8%) by genetic metabolic diseases, 18 cases (15.0%) by poisoning, 12 cases (10.0%) by viral infection, 6 cases (5.0%) by drugs, 1 case (0.8%) by bile polyp, and 1 case (0.8%) by tumor disease.Besides, the etiology of 43 cases (35.9%) was unknown.Among the cases with known etiologies, genetic metabolic and infectious diseases were the main cause of disease in infants, toddler patients were mostly caused by infectious diseases and drug/toxicants, and drug/toxicants and hereditary metabolic diseases were the dominant cause of disease in school-age children and preschoolers.Mortality rate of children with PALF was 50.0%.Among them, the mortality of Epstein-Barr virus-associated hemophagocytic syndrome, sepsis, Citrin deficiency and Tyrosinemia was higher than that of other diseases.Compared with the survival group, the total bilirubin (TB)[159.00(73.05, 274.00) μmol/L vs.62.75(2.65, 221.75)μmol/L], direct bilirubin(DB)[83.00(41.43, 160.00) μmol/L vs.38.74(10.98, 128.75) μmol/L], prothrombin time (PT)[39.60(24.93, 62.60) s vs.24.65(21.43, 29.83) s], international standardized ratio (INR)[3.40(2.30, 6.74) vs.2.09(1.85, 2.84)], and blood ammonia (NH3) levels [109.50(85.25, 149.75) μmol/L vs.80.00(60.25, 102.75) μmol/L] in the death group were significantly increased, and the diffe-rences were statistically significant(all P<0.05); while the levels of albumin[(28.72±5.88) g/L vs.(33.69±4.96) g/L], alanine aminotransferase (ALT) [586.50(223.25, 1 082.00) U/L vs.1 434.00(615.00, 3 334.50) U/L]and aspartate aminotransferase (AST) [827.50(545.00, 2 024.00) U/L vs.1 663.50(821.00, 4 886.75) U/L]in the death group were significantly decreased, and the differences were statistically significant(all P<0.05). However, the blood glucose and cholesterol levels in both groups had no statistically significant difference. Conclusion The mortality of children with PALF is high, and different age groups have different etiologies.The increase of TB, DB, PT, INR, NH3 and the ratio of hepatic encephalopathy, and the decrease of albumin, AST and ALT suggest poor prognosis. Key words: Child; Acute liver failure; Etiology; Prognosis
目的探讨小儿急性肝衰竭(PALF)的病因、预后及影响预后的因素,为PALF的临床治疗提供依据。方法收集2008年5月至2018年5月湖南省儿童医院收治的PALF患儿的临床资料,分析其病因及预后。根据预后情况将患者分为死亡组和生存组,比较两组患者的生化指标。之后,对不同资料分别采用t检验、Wilcoxon检验和χ2检验进行统计分析。结果120例PALF中,男68例,女52例,其中婴幼儿36例,幼儿34例,学龄前儿童22例,学龄儿童28例。败血症20例(16.7%)、遗传代谢性疾病19例(15.8%)、中毒18例(15.0%)、病毒感染12例(10.0%)、药物6例(5.0%)、胆汁息肉1例(0.8%)、肿瘤1例(0.8%)。病因不明43例(35.9%)。在病因已知的病例中,遗传代谢性疾病和传染性疾病是婴儿发病的主要原因,幼儿发病以感染性疾病和药物/毒物为主,而药物/毒物和遗传代谢性疾病是学龄儿童和学龄前儿童发病的主要原因。PALF患儿死亡率为50.0%。其中Epstein-Barr病毒相关的噬血细胞综合征、败血症、Citrin缺乏症和酪氨酸血症的死亡率高于其他疾病。与生存组比较,死亡组总胆红素(TB)[159.00(73.05、274.00)μmol/L vs.62.75(2.65、221.75)μmol/L]、直接胆红素(DB)[83.00(41.43、160.00)μmol/L vs.38.74(10.98、128.75)μmol/L]、凝血酶原时间(PT)[39.60(24.93、62.60)s vs.24.65(21.43、29.83)s]、国际标准化比值(INR)[3.40(2.30、6.74)vs.2.09(1.85、2.84)]、血氨(NH3)水平[109.50(85.25、149.75)μmol/L vs.80.00(60.25、102.75)μmol/L]显著升高。差异均有统计学意义(P<0.05);死亡组白蛋白[(28.72±5.88)g/L vs(33.69±4.96)g/L]、丙氨酸转氨酶(ALT) [586.50(223.25, 1 082.00) U/L vs.1 434.00(615.00, 3 334.50) U/L]、天冬氨酸转氨酶(AST) [827.50(545.00, 2 024.00) U/L vs.1 663.50(821.00, 4 886.75) U/L]水平均显著降低,差异均有统计学意义(P<0.05)。然而,两组的血糖和胆固醇水平没有统计学上的显著差异。结论小儿PALF病死率高,不同年龄组有不同的病因。TB、DB、PT、INR、NH3及肝性脑病比例升高,白蛋白、AST、ALT降低提示预后不良。关键词:儿童;急性肝衰竭;病原学;预后
{"title":"Analysis of etiology and prognosis of 120 children with pediatric acute liver failure","authors":"T. Jiang, Wen-xian Ou-yang, Y. Tan, Lian Tang, Hui Zhang, Z. Kang, Xi Zheng, Shuangjie Li","doi":"10.3760/CMA.J.CN101070-20191108-01113","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20191108-01113","url":null,"abstract":"Objective \u0000To investigate the etiology, prognosis and prognostic factors of pediatric acute liver failure(PALF), in order to provide the basis for clinical treatment of PALF. \u0000 \u0000 \u0000Methods \u0000The clinical data of children with PALF hospitalized at Hunan Children′s Hospital from May 2008 to May 2018 were collected, and the causes and prognosis were analyzed.According to the prognosis, the patients were divided into the death group and the survival group, whose biochemical indexes were then compared.After that, the statistical analysis of different data were carried out by using t-test, Wilcoxon test and χ2 test separately. \u0000 \u0000 \u0000Results \u0000In 120 PALF cases, there were 68 males and 52 females, and there were 36 infants, 34 toddlers, 22 preschoolers and 28 school-age children.Twenty cases (16.7%) were caused by sepsis, 19 cases (15.8%) by genetic metabolic diseases, 18 cases (15.0%) by poisoning, 12 cases (10.0%) by viral infection, 6 cases (5.0%) by drugs, 1 case (0.8%) by bile polyp, and 1 case (0.8%) by tumor disease.Besides, the etiology of 43 cases (35.9%) was unknown.Among the cases with known etiologies, genetic metabolic and infectious diseases were the main cause of disease in infants, toddler patients were mostly caused by infectious diseases and drug/toxicants, and drug/toxicants and hereditary metabolic diseases were the dominant cause of disease in school-age children and preschoolers.Mortality rate of children with PALF was 50.0%.Among them, the mortality of Epstein-Barr virus-associated hemophagocytic syndrome, sepsis, Citrin deficiency and Tyrosinemia was higher than that of other diseases.Compared with the survival group, the total bilirubin (TB)[159.00(73.05, 274.00) μmol/L vs.62.75(2.65, 221.75)μmol/L], direct bilirubin(DB)[83.00(41.43, 160.00) μmol/L vs.38.74(10.98, 128.75) μmol/L], prothrombin time (PT)[39.60(24.93, 62.60) s vs.24.65(21.43, 29.83) s], international standardized ratio (INR)[3.40(2.30, 6.74) vs.2.09(1.85, 2.84)], and blood ammonia (NH3) levels [109.50(85.25, 149.75) μmol/L vs.80.00(60.25, 102.75) μmol/L] in the death group were significantly increased, and the diffe-rences were statistically significant(all P<0.05); while the levels of albumin[(28.72±5.88) g/L vs.(33.69±4.96) g/L], alanine aminotransferase (ALT) [586.50(223.25, 1 082.00) U/L vs.1 434.00(615.00, 3 334.50) U/L]and aspartate aminotransferase (AST) [827.50(545.00, 2 024.00) U/L vs.1 663.50(821.00, 4 886.75) U/L]in the death group were significantly decreased, and the differences were statistically significant(all P<0.05). However, the blood glucose and cholesterol levels in both groups had no statistically significant difference. \u0000 \u0000 \u0000Conclusion \u0000The mortality of children with PALF is high, and different age groups have different etiologies.The increase of TB, DB, PT, INR, NH3 and the ratio of hepatic encephalopathy, and the decrease of albumin, AST and ALT suggest poor prognosis. \u0000 \u0000 \u0000Key words: \u0000Child; Acute liver failure; Etiology; Prognosis","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"35 1","pages":"422-425"},"PeriodicalIF":0.0,"publicationDate":"2020-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48748338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in research on Escherichia coli and pediatric infectious diseases 大肠杆菌与儿科传染病的研究进展
Q4 Medicine Pub Date : 2020-04-08 DOI: 10.3760/CMA.J.CN101070-20190219-00113
Y. Xiong, C. Zhu, Li Zhao, Qing-xiong Zhu
Escherichia coli is a common intestinal colonization bacterium in human body.It causes infectious diarrhea if it turns into a pathogenic bacterium under certain conditions.In a few cases, it can cause extraintestinal infections, such as bacterial meningitis, lower respiratory tract infection, biliary tract infection, and urinary tract infection, etc.With the increasing of antibiotic abuse, the pathogenesis of Escherichia coli in different infectious diseases has its own characteristics.The hazards, pathogenesis and treatment progress of different infectious diseases were reviewed in this paper. Key words: Escherichia coli; Infectious diarrhea; Bacterial meningitis; Urinary tract infection; Lower respiratory tract infection; Biliary tract infection
大肠杆菌是人体内常见的肠道定植细菌。如果它在一定条件下变成致病菌,就会引起传染性腹泻。少数情况下可引起肠外感染,如细菌性脑膜炎、下呼吸道感染、胆道感染、尿路感染等。随着抗生素滥用的增多,大肠杆菌在不同传染病中的发病机制各有特点。本文综述了不同传染病的危害、发病机制及治疗进展。关键词:大肠杆菌;感染性腹泻;细菌性脑膜炎;尿路感染;下呼吸道感染;胆道感染
{"title":"Advances in research on Escherichia coli and pediatric infectious diseases","authors":"Y. Xiong, C. Zhu, Li Zhao, Qing-xiong Zhu","doi":"10.3760/CMA.J.CN101070-20190219-00113","DOIUrl":"https://doi.org/10.3760/CMA.J.CN101070-20190219-00113","url":null,"abstract":"Escherichia coli is a common intestinal colonization bacterium in human body.It causes infectious diarrhea if it turns into a pathogenic bacterium under certain conditions.In a few cases, it can cause extraintestinal infections, such as bacterial meningitis, lower respiratory tract infection, biliary tract infection, and urinary tract infection, etc.With the increasing of antibiotic abuse, the pathogenesis of Escherichia coli in different infectious diseases has its own characteristics.The hazards, pathogenesis and treatment progress of different infectious diseases were reviewed in this paper. \u0000 \u0000Key words: \u0000Escherichia coli; Infectious diarrhea; Bacterial meningitis; Urinary tract infection; Lower respiratory tract infection; Biliary tract infection","PeriodicalId":9843,"journal":{"name":"中华实用儿科临床杂志","volume":"362 ","pages":"478-480"},"PeriodicalIF":0.0,"publicationDate":"2020-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41276328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华实用儿科临床杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1